Filter news by category :
02 Jun 2017 | Collaborations
Edinburgh Molecular Imaging is proud to support the University of Edinburgh team.The researchers aim to create new chemicals – known as tracers – to illuminate these unstable plaques in patients. The tracers – which contain small amounts of radioactivity – are injected into the bloodstream and...
02 Feb 2017 | Misc
The EM Imaging team hosted Paul Wheelhouse MSP, Minister for Business, Innovation and Energy at our laboratories and offices at Edinburgh Bioquarter. We took the opportunity to explain the value of being based near world leading clinicians who can help us drive our products through clinical...
21 Dec 2016 | Events
Our CEO Ian Wilson will be at the Biotech Showcase on January 9–11 in San Francisco. Contact him through the partnering system to arrange a meeting.
OBN Awards 2016 Winners Recognised at Industry Leading EventEM Imaging CEO Ian Wilson celebrates wining the Best Emerging Medtech Company Award at OBN 2016. At the OBN Awards 2016 dinner in Oxford last night, Edinburgh Molecular Imaging were awarded the Best Emerging Medtech Company Award. The...
06 Oct 2016 | Events
Ian Wilson and Diane Harbison will be attending Bio-Europe in Cologne. We are interested in speaking to potential investors for our Series B funding round or in opportunities for collaboration using our optical imaging agents. If you are interested in meeting them, please request a meeting through...
19 Sep 2016 | Collaborations, Press Releases
Edinburgh Molecular Imaging is part of an EPSRC funded consortium, led by Dr Jon Shephard of Heriot-Watt University in collaboration with Professor David Jayne from the University of Leeds to develop a revolutionary new bowel cancer surgery tool that will enable surgeons to carry out operations...
23 May 2016 | Events
On 12th May, EM Imaging took part to the EIE16 investor showcase (http://www.eie-invest.com/), along with 60 companies across the Life Sciences, Energy and ICT sectors. With more than 900 guests, the event was an absolute success. EM Imaging had the opportunity to pitch in front of potential...
07 Apr 2016 | Collaborations, Press Releases
Edinburgh and Paris, April 6th, 2016 – Edinburgh Molecular Imaging Ltd (EM Imaging) and Mauna Kea Technologies (Euronext: MKEA, OTCQX: MKEAY) today announced a clinical research collaboration to study the potential of combining EM Imaging’s in vivo optical imaging agents and Mauna Kea's...
09 Mar 2016 | Collaborations, EMI-137
Edinburgh Molecular imaging Ltd (EM Imaging) announced today that the company has received a SBRI Stratified Medicine Connecting the UK Infrastructure Phase I grant from the UK’s innovation agency, Innovate UK. The SBRI grant aims to accelerate and increase the development and adoption of...
EM Imaging has been selected as one of the 14 teams that will Pitch on Monday 7th March, 2016 at St. James's Palace. In addition, there will be a Peoples Choice vote and we would appreciate if our followers could vote for us at the following link. ow.ly/YI6dN